Search

This article discusses the synthesis and characterization of cannabinoid ethers, which are analogs of cannabinoids that are being marketed to the public. The lack of proper testing and characterization of these analogs is a concern, as companies may misrepresent their products and consumers may unknowingly consume unknown research compounds. The authors performed in-silico docking studies to analyze the binding interactions of eight cannabinoid ethers with CB1 and CB2 receptors. They also synthesized and characterized methyl ether derivatives of Delta 8-tetrahydrocannabinol (D8-THC) and hexahydrocannabinol (HHC) using nuclear magnetic resonance (NMR) spectroscopy. The study aims to provide information on the potential toxicities and effects of these analogs in an ever-changing market. [Extracted from the article]

The article focuses on the chemistry of haloalkanes and haloarenes, discussing their classification based on the number and nature of halogen atoms in their structures. Topics discussed include the nomenclature of these compounds and their physical and chemical properties, including nucleophilic and electrophilic substitution reactions.

This article discusses three different jazz albums: "Spring in Stockholm: Live at Konserthuset 1959" by Gerry Mulligan Quartet, "BBC Sessions 1968-1970" by New Jazz Orchestra/Neil Ardley Group, and "Goldenwings" by OPA. The author provides a brief overview of each album, highlighting the musicians involved and the overall sound and style of the music. The article also mentions the historical significance of these albums in the context of British and South American jazz. [Extracted from the article]

A recent report discusses research conducted at the Sri Sathya Sai Institute of Higher Learning in Andhra Pradesh, India, on the synthesis and anti-cancer activity of acetals of arjunolic acid. Arjunolic acid, a pentacyclic triterpene acid, was isolated from the heartwood of Terminalia arjuna, and a series of novel arjunolic acid acetals were synthesized and characterized. The anti-cancer activity of these synthesized acetals was investigated against colon cancer cell lines, and compounds AA-2, AA-4, AA-9, and AA-18 showed significant activity against colon cancer. Compound AA-9 was found to be the most potent against the CT-26 colon cancer cell line. Mechanistic studies revealed that compound AA-9 induced cell cycle arrest and ROS generation in cells, leading to cell death. This research has been peer-reviewed and published in the New Journal of Chemistry. [Extracted from the article]

A recent report from Chongqing University in China discusses the discovery of a new class of macrocyclic compounds called lactic acid derived crown ethers. These compounds, composed of lactic acid and benzene or iodobenzene skeletons, have larger and more stable cavities than classical macrocycles. The researchers found that these crown ethers can hide small organic molecules such as ethyl lactate, methanol, ethanol, aniline, and phenol in nuclear magnetic resonance detection. This research has been peer-reviewed and provides valuable insights into the field of Chemicals and Chemistry. [Extracted from the article]

The article presents research on novel pyrazole acetals derived from andrographolide and isoandrographolide as potential anticancer agents. Topics discussed include the synthesis and characterization of these compounds, their evaluation against various cancer cell lines, and their promising anticancer activity, particularly the compound with the best efficacy against colon cancer cells.

Researchers from Ufa State Petroleum Technological University in Ufa, Russia have conducted a study on the cytotoxic and antioxidant activity of a series of 4-methylene-1,3-dioxolane acetals. The compounds synthesized did not exhibit cytotoxic activity against human colon, liver, lung, and breast cancer cell lines, nor did they increase tumor cell proliferation. However, compounds 14 and 15 showed some ability to neutralize the negative effects of reactive oxygen species. This research was supported by the Ministry of Education and Science of Russia. [Extracted from the article]

(Bloomberg) -- Bitcoin fell below the $60,000 level as part of a broad crypto market retreat that included a sharp drop in second-largest token Ether.The biggest digital asset shed 5% to change hands at $58,840 as of 6:17 a.m. Wednesday in Singapore. Ether at one point lost more than 7% before trading at about $2,440.Major tokens are unwinding the lift from they received last week from Federal Reserve Chair Jerome Powell's indication that the US central bank is on course to cut benchmark rates from a more than two-decade high.©2024 Bloomberg L.P.By Sunil JagtianiReported by Author [Extracted from the article]

A patent has been issued for a process to make amino diaryl ethers and amino diaryl ethers hydrochloride salts. The patent describes a new method that addresses the contamination and side reactions associated with previous processes. The inventors found that using a palladium catalyst in a polar, aprotic solvent or a C3-C10 alcohol resulted in compounds with a high level of purity. Additionally, they discovered that transforming the compounds into monohydrochloride salts improved their properties, such as higher melting points and improved solubilities. The patent provides detailed claims for the monohydrochloride salts and their pharmaceutical formulations. [Extracted from the article]

During the first week of trading, nine US ETFs holding Ethereum experienced outflows of $340 million as investors withdrew money from a high-fee legacy product that was converted to an exchange-traded fund. However, the eight new Ether ETFs approved by the US Securities and Exchange Commission received inflows of $1.17 billion in the four trading days ending on July 26. BlackRock, Bitwise, and Fidelity saw the largest inflows, while Grayscale's incumbent Ethereum Trust lost $1.5 billion as investors took the opportunity to cash out. The price of Ether has dropped 4.6% since the ETFs began trading on July 23. [Extracted from the article]

A study conducted by researchers at Kermanshah University of Medical Sciences in Iran explored the antifungal effects of various extracts from three species of Artemisia plants on common dermatophytic fungi. The extracts were obtained using different solvents and were tested against Trichophyton rubrum, Trichophyton verrucosum, Epidermophyton floccosum, and Microsporum canis. The results showed that extracts from Artemisia scoparia exhibited the broadest range of activity, with lipophilic compounds in the petroleum ether and dichloromethane extracts showing significant antidermatophytic activity. The study provides valuable insights into potential alternative treatments for dermatophytosis, a skin disease that is becoming increasingly resistant to conventional therapies. [Extracted from the article]

Nomura Holdings Inc.'s digital-asset unit, Laser Digital, plans to launch a higher-yielding alternative to the recently launched Ether exchange-traded funds (ETFs). The Ether ETFs did not include staking, a process that allows investors to earn passive income by temporarily making their tokens available to the Ethereum network. Laser Digital's fund, set to launch in early September, will be open to accredited investors and aims to provide institutional investors with exposure to the "carry component" from Ethereum. The fund will be supported by Galaxy Digital and crypto startup Dinero, and will not be available in the US immediately after launch. [Extracted from the article]

Ether, the second-largest cryptocurrency, experienced a 6% decline in value following a drop in global equity markets. This decline was attributed to a decrease in investor sentiment after a poor performance by US technology stocks. The conversion of the Grayscale Ethereum Trust into an exchange-traded fund (ETF) also contributed to caution among investors, with $811 million leaving the fund since the conversion. However, it is suggested that the sell-off pressure on Ether may soon subside if market sentiment improves. [Extracted from the article]

The first US exchange-traded funds (ETFs) that directly invest in Ether, the cryptocurrency of the Ethereum blockchain, had a strong debut with over $1 billion in shares traded. While this is lower than the trading volume of spot-Bitcoin ETFs launched in January, it is still considered a robust start. BlackRock's iShares Ethereum Trust ETF and Grayscale's Ethereum Trust were among the top performers, with high trading values. Analysts have varying forecasts for the amount of cash that Ether funds could attract, with estimates ranging from $3.2 billion to $6.4 billion. The adoption of Ether ETFs may be quicker due to investors' previous experience with Bitcoin funds. However, Bitcoin's first-mover advantage and existing allocations to Bitcoin ETFs may limit the potential for Ether fund flows. The price of Ether remained relatively stable during this period. [Extracted from the article]

The first US exchange-traded funds (ETFs) that directly invest in Ether, the cryptocurrency of the Ethereum network, have seen strong trading volumes on their debut. Over $500 million worth of shares were traded across nine ETFs in the first few hours after the market opened. While this is lower than the trading volume of spot-Bitcoin ETFs launched in January, it is still considered a strong start. Analysts have varying forecasts for the amount of cash these Ether funds could attract, with estimates ranging from $3.2 billion to $6.4 billion in one-year flows. The popularity of Bitcoin ETFs earlier this year may accelerate investor adoption of Ether ETFs. However, some analysts believe that Bitcoin's first-mover advantage and its status as "digital gold" may limit the potential for Ether fund flows. [Extracted from the article]

Several asset management firms, including BlackRock, Fidelity Investments, Invesco, and Bitwise Asset Management, have submitted paperwork to the Securities and Exchange Commission (SEC) outlining the fees they would charge for their respective Ether exchange-traded funds (ETFs). The proposed fees range from 0.19% to 2.5%. The battle for potential Ether ETF assets is heating up, with the funds expected to launch soon pending final approval from the SEC. These ETFs could attract between $4.7 billion to $5.4 billion in inflows in the six months after their debut, according to Citigroup. [Extracted from the article]

The US Securities and Exchange Commission (SEC) has given indications to four issuers of spot-Ether exchange-traded funds (ETFs) to file paperwork for potential approval. Three of the issuers have been told that trading may begin on July 23. These ETFs would hold Ether directly and could see inflows of between $4.7 billion to $5.4 billion in the six months after their debut. However, researchers at Citigroup suggest that the flows could be lower due to the earlier launch of Bitcoin ETFs. Asset managers have made concessions to win SEC approval, including not participating in staking. The price of Ether is expected to fall initially after the ETF debut but could recover and outperform Bitcoin in the coming months. [Extracted from the article]

Research firm Kaiko predicts that the upcoming launch of spot Ether exchange-traded funds (ETFs) could cause Ether to outperform Bitcoin. The price of Ether relative to Bitcoin has already increased following the first stage of approval for Ether ETFs from the US Securities and Exchange Commission. Although the price of Ether has fallen recently, the increased ratio suggests that the cryptocurrency's performance may improve after the ETFs begin trading. The approval of Ether ETFs would allow institutional investors to diversify their crypto portfolios, potentially leading to further price increases for Ether. [Extracted from the article]

A study conducted by researchers at George Mason University in Manassas, Virginia, has provided new insights into the potential therapeutic strategy for resolving chronic inflammation. The study focused on the activation of the aminopeptidase (AP) activity of leukotriene A4 hydrolase (LTA4H). Novel derivatives of ARM1 were synthesized and screened, with one derivative, called AMP, found to be a potent AP activator. However, despite its AP activity, AMP did not affect the hydrolysis of the natural ligand of LTA4H. The study concluded that accelerated cleavage of a specific substrate is not sufficient for predicting therapeutic potential. [Extracted from the article]

A recent report from Guangxi University of Chinese Medicine discusses the potential anti-hepatocellular carcinoma (HCC) activity of the petroleum ether fraction of Illicium simonsii Maxim (PEIM). The researchers identified 64 compounds in the PEIM and found that it had anti-HCC activity against HepG2 cells. The PEIM was also able to modulate the expression of inflammatory factors and induce HepG2 cell apoptosis. However, further studies are needed to fully understand the mechanisms of action and to explore the potential of the PEIM as an anti-HCC drug. [Extracted from the article]

A recent study conducted at the Nagoya Institute of Technology in Japan explores the synthesis of long-chain perfluoroalkyl ethers, which are sought-after compounds in the field of Obesity, Fitness, and Wellness. The researchers used triglyme to stabilize short-lived, longer-chain perfluoroalkoxy anions, allowing for efficient nucleophilic perfluoroalkoxylation reactions. This method offers a versatile tool for designing perfluoroalkyl ethers with complex moieties, including those found in heterocycles and drug molecules. The study also demonstrates the utility of the resulting halo-perfluoroalkoxyl adducts through various chemical transformations. Financial support for this research was provided by Core Research for Evolutional Science and Technology (CREST). [Extracted from the article]

Inventors Griggs, Jiang, Kao, and Yates have filed a patent application for an insertion tool used in the treatment of eye diseases, specifically glaucoma. The tool is designed to lower intraocular pressure by inserting a treatment device into a subconjunctival pocket of the patient's eye. The device is folded or furled around the insertion tool and then unfurled within the pocket to reduce scarring and post-operative discomfort. The patent application provides detailed descriptions of the device and its various embodiments. [Extracted from the article]

A recent report from Emory University explores the association between prenatal exposure to polybrominated diphenyl ethers (PBDEs) and oxidative stress during pregnancy. The study, conducted on participants from the Chemicals in Our Bodies cohort in the San Francisco Bay Area, found that higher concentrations of PBDEs were associated with increased levels of oxidative stress biomarkers. The researchers suggest that oxidative stress may be a potential biological pathway through which PBDE exposure could contribute to preterm birth. This study provides valuable insights into the potential health effects of PBDE exposure during pregnancy. [Extracted from the article]

A recent report from the University of Florence in Italy explores the use of 3D printing technology to create magnesium silicate ceramics for bone tissue regeneration. The researchers investigated the effects of sodium orthophosphate and cellulose ethers on the printability and hardening time of the cement formulations. The study found that cellulose derivatives influenced the printability without affecting the hardening time, which could be adjusted by the addition of sodium phosphate. The fine-tuned formulations resulted in 3D-printed forsterite bioceramics that could potentially be used as cancellous bone scaffolds. [Extracted from the article]

Asset managers are hopeful that the Securities and Exchange Commission (SEC) will approve the first US exchange-traded funds (ETFs) that directly invest in Ether by mid-July. The SEC has given ETF applicants until July 8 to submit updated paperwork, and there may be additional filings after that. The recent feedback from the SEC to issuers consisted of minor questions that are being addressed. If approved, the key question is whether Ether portfolios will generate the same demand as Bitcoin ETFs, which have amassed $52 billion in assets. [Extracted from the article]

Asset managers are hopeful that the US Securities and Exchange Commission (SEC) will approve the first US exchange-traded funds (ETFs) that directly invest in Ether by mid-July. The SEC has given ETF applicants until July 8 to submit updated paperwork, and there may be additional filings after that. Firms such as BlackRock, Fidelity Investments, 21Shares, and Invesco have filings awaiting approval. The demand for these Ether ETFs is uncertain, but the approval of Bitcoin ETFs in January generated $52 billion in assets. Ether's price dropped slightly to $3,409, but it has risen 50% this year. [Extracted from the article]

Bitcoin's prominence in the cryptocurrency market is being overshadowed by the rising popularity of Ether and Solana. The recent hype surrounding cryptocurrency exchange-traded funds (ETFs) has shifted towards these smaller digital assets. Solana experienced a significant surge after VanEck filed an application to start an ETF for the token, while Ether has surpassed Bitcoin in performance this year as final approvals for funds focused on the coin draw closer. Analysts predict that Ether ETFs may attract $5 billion in net inflows in the first five months, and Fundstrat's Head of Digital Asset Strategy believes that sentiment around the Ether ETF launch is too bearish. However, it is uncertain whether the SEC will approve Solana ETFs, as the agency has previously identified Solana as an unregistered security. [Extracted from the article]

A research study conducted at Sun Yat-sen University in Guangzhou, China, has developed a new method for synthesizing oxime ethers, which are compounds with potential medicinal properties. The researchers used a one-pot tandem electrochemical system that involved magnesium oxide nanoparticles derived from metal-organic frameworks. This method demonstrated high efficiency and selectivity in producing oxime ethers, offering a green and safe alternative for the synthesis of organic nitrogen drug molecules. The research was supported by various funding sources and has been peer-reviewed. [Extracted from the article]

Restaking services on the Ethereum blockchain, where investors can earn additional yield on their cryptocurrency, could potentially lead to the development of an "internet bond" market, according to S&P Global Ratings. Restaking involves compounding rewards by reinvesting them into other protocols, similar to lending out securities in fixed-income markets. While there are currently only a few active restaking services, their growth is anticipated. The risks associated with restaking are primarily operational and unique to each service, but financial risks could arise due to speculation. However, S&P does not currently foresee significant ecosystem-level financial risk. [Extracted from the article]

The Ether token, which is part of the Ethereum blockchain, experienced a significant increase in value amid speculation that regulatory scrutiny by the US Securities and Exchange Commission (SEC) may be easing. The SEC has been investigating whether Ether is an unregistered security, which could impact its demand. However, Consensys, a developer of Ethereum, announced that the SEC is closing its investigation into Ethereum 2.0. The SEC has not yet commented on these claims. While Bitcoin is considered a commodity, the SEC has not definitively stated whether Ether is a security, causing concern among crypto enthusiasts. [Extracted from the article]

The Securities and Exchange Commission (SEC) Chair, Gary Gensler, stated that final approval for exchange-traded funds (ETFs) linked to Ether, the second-most popular digital asset, could be granted during the summer. Gensler's comments suggest that the launch of Ether ETFs may be approaching, as the SEC has already approved initial applications from several exchanges to trade these products. The approval of issuer registration statements will depend on the quality of disclosures to investors, and the process is currently being handled at the staff level. Fund managers from various companies, including VanEck Associates, ARK Investment Management, BlackRock Inc., and Fidelity Investments, would still require the SEC's approval to establish this new asset class. [Extracted from the article]

Nonfungible tokens (NFTs) are losing their appeal as investors turn to new Ether exchange-traded funds (ETFs). Google searches for NFTs have reached their lowest level since 2021, and NFT sales are down by over 6% compared to last year. The US Securities and Exchange Commission's move towards approving ETFs investing in Ether has caused investors to shift away from NFTs. Prices for popular NFT collections have dropped by 40% to 50% this year, and many collections continue to sell off or remain flat. However, NFT marketplace Magic Eden has been gaining market share. [Extracted from the article]

According to a report from CoinShares International Ltd., investment products holding Ether, the second-largest cryptocurrency, experienced the largest weekly inflows since March. This surge in investor inflows is attributed to a surprise decision by the U.S. Securities and Exchange Commission (SEC) to advance the approval process for a U.S. Ethereum exchange-traded fund (ETF). In addition, Bitcoin products also saw significant inflows, totaling almost $2 billion last week, with a year-to-date total of $16.7 billion. The price of Bitcoin has increased by approximately 65% this year, largely driven by the approval of U.S. Bitcoin ETFs in January. BlackRock Inc.'s iShares Bitcoin Trust has become the world's largest fund for Bitcoin, surpassing Grayscale's Bitcoin Trust with over $21 billion in assets. [Extracted from the article]

A recent study conducted by researchers at the Dalian Institute of Chemical Physics, Chinese Academy of Sciences, has developed a new method for the oxidation of aryl ethers into ester products using visible light and oxygen as the oxidant. The researchers utilized a photocatalytic reaction with a specific catalyst to generate chlorine radicals from various chloride sources, which then activated the aryl ether C(sp3)-H bonds. This method provides a convenient and environmentally friendly approach to the functionalization of ether C(sp3)-H bonds, allowing for their utilization in organic synthesis and pharmaceutical chemistry. The findings of this study were published in the Chinese Journal of Catalysis. [Extracted from the article]

Analysts predict that the debut of US exchange-traded funds (ETFs) for the cryptocurrency Ether may not generate as much demand as Bitcoin ETFs. BlackRock and Fidelity Investments are among the issuers seeking approval to list Ether funds, but JPMorgan Chase & Co. strategists expect smaller net inflows for Ether compared to Bitcoin. The success of Bitcoin ETFs was attributed to the narrative of Bitcoin as digital gold, which Ether lacks. Additionally, Ether ETFs will not offer staking rewards for blockchain maintenance. However, some experts remain optimistic about the potential for Ether ETFs, citing the popularity of the Ethereum blockchain and the potential for application and innovation within the Ethereum ecosystem. [Extracted from the article]

The US regulatory shift towards allowing exchange-traded funds (ETFs) for Ether has sparked increased speculation and bets on the digital asset's gains. The US Securities & Exchange Commission's decision led to a 26% surge in Ether over the past week, the largest weekly increase since the 2021 crypto bull market. However, questions remain about the demand for these products, as Ether is less well-known than Bitcoin. Additionally, the omission of staking in spot-Ether ETFs may dampen interest in these funds compared to holding the tokens directly. Further SEC approvals are required before major issuers like BlackRock and Fidelity can launch Ether ETFs. [Extracted from the article]

The Securities and Exchange Commission (SEC) has given approval for the listing of exchange-traded funds (ETFs) that invest directly in the Ether token, the second-largest digital asset. However, fund managers still need separate approval from the agency before they can launch these products. While some experts believe that Ether ETFs may not attract the same level of demand as Bitcoin products due to its smaller market size and lower awareness, others see this development as a major milestone for the crypto industry. The SEC's decision also has wider policy implications regarding whether Ether is considered a security or a commodity. [Extracted from the article]

The U.S. Securities and Exchange Commission (SEC) has approved proposals from Cboe, NYSE Arca, and Nasdaq to list exchange-traded funds (ETFs) that track the value of Ether, the native cryptocurrency of the Ethereum blockchain. This move brings the U.S. closer to listing Ether ETFs, with investment giants like BlackRock, Fidelity, and Franklin Templeton seeking separate approvals to manage these investment products. The approval is seen as a positive development for the crypto industry, as the SEC had previously raised concerns about Ether's classification as a security. Canada already has Ether ETFs, with Toronto-based crypto firm Ether Capital converting into an ETF managed by Purpose Investments. [Extracted from the article]

The Securities and Exchange Commission (SEC) has given approval for the trading of exchange-traded funds (ETFs) that directly invest in the cryptocurrency Ether. This decision is seen as a significant milestone for the digital-asset industry. Investment companies such as VanEck, ARK Investment Management, BlackRock Inc., and Fidelity Investments are now competing to be the first to launch a spot Ether ETF. The SEC's announcement also has broader implications for US financial policy, as it raises questions about whether Ether should be classified as a security. The Commodity Futures Trading Commission (CFTC), another major US market regulator, has previously indicated that it does not consider Ether to be a security. [Extracted from the article]

The Securities and Exchange Commission (SEC) has given approval for the trading of exchange-traded funds (ETFs) that directly invest in the cryptocurrency Ether. This decision by the SEC allows venues run by Cboe Global Markets Inc., Nasdaq, and the New York Stock Exchange to list products tied to Ether. Investment companies such as VanEck, ARK Investment Management, BlackRock Inc., and Fidelity Investments are now competing to launch the first spot Ether ETF. The SEC's decision has broader implications for US financial policy and the classification of Ether as a security. [Extracted from the article]

Hong Kong is exploring the possibility of allowing staking for exchange-traded funds (ETFs) that invest in Ether, a cryptocurrency. This move could provide a source of passive income that is currently unavailable to US issuers. The Securities and Futures Commission (SFC) has been in discussions with crypto ETF issuers in Hong Kong about offering staking services through licensed platforms. If approved, this could increase demand for Hong Kong's spot-crypto ETFs and give the city an advantage over the US in terms of regulatory approval for spot-Ether ETFs. Staking involves locking tokens on the Ethereum network to validate transactions and currently yields around 4% annually. Hong Kong is competing with other cities to become a digital-asset hub and is also considering expanding its licensed digital-asset exchanges and developing a framework for stablecoins. [Extracted from the article]

Hong Kong is considering allowing staking for exchange-traded funds (ETFs) investing in Ether, which could provide a source of passive income. The Securities and Futures Commission has been in discussions with crypto ETF issuers about offering staking services through licensed platforms. If approved, this move could boost demand for Hong Kong's spot-crypto ETFs and give the city an advantage over the US, where staking is not currently allowed for Ether ETFs. Staking involves locking tokens on the Ethereum network to validate transactions and currently pays out around 4% annually. Hong Kong is aiming to become a digital-asset hub and is also exploring applications for licensed digital-asset exchanges and a framework for stablecoins. [Extracted from the article]

Regulator approves exchange requests to list spot ether funds tracking the price of the $458 billion asset. But trading won't start right away. [ABSTRACT FROM AUTHOR]

There is growing optimism in cryptocurrency markets that regulators will approve exchange-traded funds (ETFs) that invest directly in Ether. The US Securities and Exchange Commission (SEC) has requested updates to filings from potential issuers and stock exchanges, indicating a potential rise in prospects for SEC approval. Fidelity Investments has also updated its registration statement for a proposed spot-Ether ETF, stating that it will not invest in derivatives and will keep the Ether it buys out of staking programs. The SEC has a May 23 deadline to approve or deny an application from VanEck. The approval of ETFs could lead to significant inflows of funds into Ether. [Extracted from the article]

Crypto prices, particularly the second-largest token Ether, have experienced a surge due to signs of progress towards the approval of exchange-traded funds (ETFs) in the US. This development mirrors the investor enthusiasm that accompanied the listing of US Bitcoin funds in January, which led to a rally in Bitcoin's value. Ether saw a significant increase of almost 14% on Monday, the largest jump since November 2022. The US Securities & Exchange Commission (SEC) has contacted exchanges and potential Ether ETF issuers, indicating a potential rise in the odds of SEC approval. However, a green light is not guaranteed. The SEC does not comment on individual filings. The Ethereum blockchain, where Ether is the native token, is widely used for decentralized financial services. Bloomberg Intelligence ETF analysts have increased the estimated probability of a spot-Ether ETF approval from 25% to 75%. Some fund companies were expecting a rejection due to less robust private talks with the SEC compared to the launch of spot-Bitcoin ETFs. However, caution remains among some investors who anticipate the SEC moving slower than the markets expect. The SEC reluctantly approved US spot-Bitcoin ETFs earlier this year after a court reversal in 2023. BlackRock and Fidelity, among others, are also seeking to launch Ether funds. The digital-asset industry sees ETFs as a means of expanding crypto's investor base, with various entities already investing in Bitcoin funds. [Extracted from the article]

Ether, the second-largest cryptocurrency, experienced a significant surge in value, rising by as much as 14% to approximately $3,490. This increase was driven by speculation that regulators may be more open to approving exchange-traded funds (ETFs) that directly invest in Ether. Bloomberg Intelligence ETF analyst Eric Balchunas raised the estimated probability of an Ether ETF approval to 75%. The US Securities and Exchange Commission (SEC) is expected to announce a decision on at least one Ether ETF application by May 23, although some fund companies anticipate a rejection. However, not all traders are convinced that the SEC is warming up to an Ether ETF. [Extracted from the article]